CRISPR

CRISPR2-wrn

ID
ZDB-CRISPR-260408-8
Name
CRISPR2-wrn
Previous Names
None
Target
Sequence
5' - TGTGTGGTGGCCACA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "GTG" at the 3' end.
Genome Resources
None
Target Location
View all 5 target locations
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
agu26 wrn
Expression
Gene expression in Wild Types + CRISPR2-wrn
No data available
Phenotype
Phenotype resulting from CRISPR2-wrn
No data available
Phenotype of all Fish created by or utilizing CRISPR2-wrn
Phenotype Fish Conditions Figures
whole organism glycogen decreased amount, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 standard conditions Figure 5 with image from Ujibe et al., 2026
whole organism viability, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 control Figure 1 with imageFigure 5 with image from Ujibe et al., 2026
whole organism glucose decreased amount, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 standard conditions Figure 5 with image from Ujibe et al., 2026
whole organism viability, ameliorated mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 increased food availability Figure 5 with image from Ujibe et al., 2026
whole organism decreased length, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 standard conditions Figure 1 with image from Ujibe et al., 2026
whole organism lipid decreased amount, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 standard conditions Figure 5 with image from Ujibe et al., 2026
whole organism dead, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9 limited food availability Figure 5 with image from Ujibe et al., 2026
pancreas Ab12-h2afx labeling increased distribution, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9; jh1Tg standard conditions Figure 4 with image from Ujibe et al., 2026
exocrine pancreas EGFP expression spatial pattern, ameliorated mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9; jh1Tg increased food availability Figure 5 with image from Ujibe et al., 2026
intestine Ab12-h2afx labeling increased distribution, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9; jh1Tg standard conditions Figure 4 with image from Ujibe et al., 2026
pancreas apoptotic process increased process quality, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9; jh1Tg standard conditions Figure 4 with image from Ujibe et al., 2026
exocrine pancreas EGFP expression decreased distribution, abnormal mitfaw2/w2; wrnagu26/agu26; mpv17a9/a9; jh1Tg control Figure 3 with imageFigure 4 with imageFigure 5 with image from Ujibe et al., 2026
Citations